Immunotherapy

Results: 985



#Item
1# 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,*,#, Stephen M. Shaw 1,*, Kim Wi

# 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,*,#, Stephen M. Shaw 1,*, Kim Wi

Add to Reading List

Source URL: www.biolinerx.com

Language: English - Date: 2017-03-27 02:02:40
    2Microsoft Word - ST64 Cancer Immunotherapy v1.0.docx

    Microsoft Word - ST64 Cancer Immunotherapy v1.0.docx

    Add to Reading List

    Source URL: www.proimmune.com

    Language: English - Date: 2016-06-13 06:09:49
      3April 18, 2018 Torii Pharmaceutical Co., Ltd. Price Listing on the NHI Reimbursement List and Launch of “CEDARCURE® Japanese Cedar Pollen Sublingual Tablets”, an Allergen Immunotherapy Tablet for Japanese Cedar Poll

      April 18, 2018 Torii Pharmaceutical Co., Ltd. Price Listing on the NHI Reimbursement List and Launch of “CEDARCURE® Japanese Cedar Pollen Sublingual Tablets”, an Allergen Immunotherapy Tablet for Japanese Cedar Poll

      Add to Reading List

      Source URL: www.torii.co.jp

      Language: English - Date: 2018-04-17 00:37:00
        4第42回 日本免疫学会学術集会 クリニカルセミナー 2 Sublingual immunotherapy for Japanese cedar pollinosis

        第42回 日本免疫学会学術集会 クリニカルセミナー 2 Sublingual immunotherapy for Japanese cedar pollinosis

        Add to Reading List

        Source URL: www.jsi-men-eki.org

        Language: Japanese - Date: 2013-12-26 23:59:34
          5President of ORPHEUS Robert Adam Harris Professor in Immunotherapy in Neuroinflammation Karolinska Institutet Personal details:

          President of ORPHEUS Robert Adam Harris Professor in Immunotherapy in Neuroinflammation Karolinska Institutet Personal details:

          Add to Reading List

          Source URL: www.orpheus-med.org

          Language: English - Date: 2016-04-12 05:03:24
            6BOOK PERFORMANCE METRICS NOV 30, 2017 Immunotherapy - Myths, Reality, Ideas, Future Edited by: Krassimir Metodiev

            BOOK PERFORMANCE METRICS NOV 30, 2017 Immunotherapy - Myths, Reality, Ideas, Future Edited by: Krassimir Metodiev

            Add to Reading List

            Source URL: www.imab-bg.org

            Language: English - Date: 2017-12-05 05:37:22
              7FALL/WINTERUCSF Oncology Connection Oncologist Lawrence Fong, MD, is leading UCSF’s newly launched Cancer Immunotherapy Program

              FALL/WINTERUCSF Oncology Connection Oncologist Lawrence Fong, MD, is leading UCSF’s newly launched Cancer Immunotherapy Program

              Add to Reading List

              Source URL: cancer.ucsf.edu

              - Date: 2016-11-10 15:08:46
                8Cancer Immunotherapy & Personalized Vaccines Alex Rubinsteyn Mount Sinai, Hammer Lab

                Cancer Immunotherapy & Personalized Vaccines Alex Rubinsteyn Mount Sinai, Hammer Lab

                Add to Reading List

                Source URL: www.rubinsteyn.com

                - Date: 2017-03-28 12:28:33
                  9  IMMUNOTHERAPY AND MELANOMA RESEARCH GET BIG BOOST WITH BLOOMBERG-KIMMEL INSTITUTE Washington,  DC,  March  30,  2016  –The  promising  field  of  immunotherapy,  in  which  mela

                    IMMUNOTHERAPY AND MELANOMA RESEARCH GET BIG BOOST WITH BLOOMBERG-KIMMEL INSTITUTE Washington,  DC,  March  30,  2016  –The  promising  field  of  immunotherapy,  in  which  mela

                  Add to Reading List

                  Source URL: www.curemelanoma.org

                  - Date: 2016-03-30 14:45:05